Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.66 |
| ▸ | MMP8 | P22894 | 1/20 | 0.66 |
| ▸ | MMP14 | P50281 | 1/20 | 0.66 |
| ▸ | MMP1 | P03956 | 1/20 | 0.46 |
| ▸ | PLK1 | P53350 | 1/20 | 0.42 |
| ▸ | FDPS | P14324 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.38 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.35 |
| ▸ | NOS3 | P29474 | 2/20 | 0.35 |
| ▸ | NOS1 | P29475 | 2/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26135898 | 0.98 | MMP2 (0.63) | MMP2MMP8MMP14MMP1PLK1 | |
| SCHEMBL2150897 | 0.98 | MMP2 (0.63) | MMP2MMP8MMP14MMP1PLK1 | |
| SCHEMBL2150903 | 0.87 | MMP2 (0.51) | MMP2MMP8MMP14MMP1PLK1 | |
| SCHEMBL8589347 | 0.83 | MMP2 (0.66) | MMP2MMP8MMP14MMP1FDPS | |
| SCHEMBL10788079 | 0.83 | MMP8 (0.66) | MMP2MMP8MMP14MMP1FDPS | |
| SCHEMBL29406152 | 0.82 | MMP1 (0.69) | MMP2MMP8MMP14MMP1PLK1 | |
| SCHEMBL8588507 | 0.81 | MMP2 (0.49) | MMP2MMP8MMP14FDPSALDH1A1 | |
| Tiludronic Acid SCHEMBL18988 | 0.79 | MMP2 (1.00) | MMP2MMP8MMP14MMP1FDPS | |
| SCHEMBL7177633 | 0.79 | MMP2 (0.59) | MMP2MMP8MMP14MMP1FDPS | |
| SCHEMBL8588143 | 0.79 | MMP2 (0.59) | MMP2MMP8MMP14MMP1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250213597-A1 | AGENT FOR INDUCING PROLIFERATION OR DIFFERENTIATION OF CHONDROCYTE | TOHOKU UNIVERSITY (JP) | 2025-07-03 | — | — | US | claimed |
| EP-4501331-A1 | AGENT FOR INDUCING PROLIFERATION OR DIFFERENTIATION OF CHONDROCYTE | Tohoku University (JP) | 2025-02-05 | — | — | EP | claimed |
| CN-119212712-A | Proliferation or differentiation inducer for chondrocytes | 国立大学法人东北大学 | 2024-12-27 | — | — | CN | claimed |
| WO-2023190685-A1 | AGENT FOR INDUCING PROLIFERATION OR DIFFERENTIATION OF CHONDROCYTE | 国立大学法人東北大学 | 2023-10-05 | — | — | WO | claimed |
| EP-2340841-B1 | OSTEOGENESIS PROMOTER COMPRISING [4-(METHYLTHIO)PHENYLTHIO]METHANEBISPHOSPHONIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT | UNIV TOHOKU (JP) | 2016-11-09 | — | — | EP | claimed |
| US-20110230447-A1 | OSTEOGENESIS PROMOTER COMPRISING [4-(METHYLTHIO)PHENYLTHIO]METHANEBISPHOSPHONIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT | TOHOKU UNIVERSITY (JP) | 2011-09-22 | — | — | US | claimed |
| EP-2340841-A1 | OSTEOGENESIS PROMOTER COMPRISING [4-(METHYLTHIO)PHENYLTHIO]METHANEBISPHOSPHONIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT | Tohoku University (JP) | 2011-07-06 | — | — | EP | claimed |
| US-6579860-B1 | Thrombocytosis inhibitor, methanebisphosphonic acid derivatives | TORAY INDUSTRIES, INC. (JP) | 2003-06-17 | — | — | US | claimed |
| US-6555529-B1 | Administering (4-methylthiophenylthio)methane-1,1-bisphosphonic acid for treatment of bone marrow disorders such as inflammatory disease, myeloma, anemia, and leukemia | TORAY INDUSTRIES, INC. (JP) | 2003-04-29 | — | — | US | claimed |
| EP-0998934-A1 | REMEDIES FOR INTRAMEDULLARY DISEASES | TORAY INDUSTRIES, INC. (JP) | 2000-05-10 | — | — | EP | claimed |
| US-20250213597-A1 | AGENT FOR INDUCING PROLIFERATION OR DIFFERENTIATION OF CHONDROCYTE | TOHOKU UNIVERSITY (JP) | 2025-07-03 | — | — | US | disclosed |
| EP-4501331-A1 | AGENT FOR INDUCING PROLIFERATION OR DIFFERENTIATION OF CHONDROCYTE | Tohoku University (JP) | 2025-02-05 | — | — | EP | disclosed |
| CN-119212712-A | Proliferation or differentiation inducer for chondrocytes | 国立大学法人东北大学 | 2024-12-27 | — | — | CN | disclosed |
| WO-2024247839-A1 | ANTIOXIDANT | 風間 順一郎 | 2024-12-05 | — | — | WO | disclosed |
| WO-2023190685-A1 | AGENT FOR INDUCING PROLIFERATION OR DIFFERENTIATION OF CHONDROCYTE | 国立大学法人東北大学 | 2023-10-05 | — | — | WO | disclosed |
| EP-0594857-B1 | METHANEDIPHOSPHONIC ACID DERIVATIVE, PRODUCTION THEREOF AND MEDICINAL USE THEREOF | TORAY INDUSTRIES (JP) | 1998-04-29 | — | — | EP | disclosed |
| US-5683992-A | TREATMENT OF RHEUMATISM, BONE DISORDERS, ANTIINFLAMMATORY, SUPPRESSION OF INTERLEUKIN-1, ANTIOXIDANT, TREATMENT OF AUTOIMMUNE DISEASES | TORAY INDUSTRIES, INC. (JP) | 1997-11-04 | — | — | US | disclosed |
| EP-0725070-A1 | PROCESS FOR PRODUCING METHANEDIPHOSPHONIC ACID COMPOUND | TORAY INDUSTRIES, INC. (JP) | 1996-08-07 | — | — | EP | disclosed |
| US-5527940-A | SUPPRESSES INTERLEUKIN-1 AND BONE DESTRUCTION DURING OSTEOPOROSIS; ANTIINFLAMMATORY AGENTS | TORAY INDUSTRIES, INC. (JP) | 1996-06-18 | — | — | US | disclosed |
| EP-0594857-A1 | METHANEDIPHOSPHONIC ACID DERIVATIVE, PRODUCTION THEREOF AND MEDICINAL USE THEREOF | TORAY INDUSTRIES, INC. (JP) | 1994-05-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250213597-A1 | AGENT FOR INDUCING PROLIFERATION OR DIFFERENTIATION OF CHONDROCYTE | MKI67, STAT3, FGF1 | MMP2 177/4885MMP8 305/4885MMP14 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.